Chiral Plasmonic Assays will provide new solutions to rapid (< 1 hr) diagnostics for medical and veterinary applications as well as rapid pre-screening assays for drug discovery processes. The assays will utilise a new bio-structurally sensitive spectroscopic technique, chiral plasmonic sensing, that utilises high-throughput plasmonic devices and imaging technology pioneered and manufactured in Glasgow. This project will aim to detect specific pathogen markers that include serious diseases such as sepsis, fungal infections in cancer patients and mastitis (Bovine) amongst other exploratory work for drug screening applications.
The research will require exploration of plasmonic sensor designs, surface functionalisation and medical diagnostics. The prospective student will acquire skills in nanoscale fabrication and characterisation, plasmonic biosensing and biochemistry to develop the diagnostic assays. As part of an EPSRC Innovation grant, the research will provide impact by feeding into the commercialisation activities.
Funding is available to cover tuition fees for UK/EU applicants for 3.5 years, as well as paying a stipend at the Research Council rate (estimated £14,999 for Session 2019/20).